accessibility menu, dialog, popup

UserName
Viewing profile as user:

Organic Acids

Organic compounds with acidic properties, organic acids are generally weak acids incapable of complete dissociation in water. Available in a range of chemical compositions and acid strengths, they can be used for various industrial and everyday applications.
Citric Acid (2)
Gallic Acid (1)
Trifluoroacetic Acid (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (3)

special interests

  • (1)
Search Within Results
Keyword Search:
1 – 4 of 4 results
1

eMolecules​ Ambeed / 4-Methylhexanoicacid / 100mg / 626257063 / A545679 / / 1561-11-1 / MFCD00870848 / 130.187 / C7H14O2

Ambeed / 4-Methylhexanoicacid / 100mg / 626257063 / A545679 / / 1561-11-1 / MFCD00870848 / 130.187 / C7H14O2

ENCOMPASS_PREFERRED
2

eMolecules​ Ambeed / trans-4-Pentyl-(11-bicyclohexyl)-4-carboxylic acid / 1g / 552551796 / A123557 / / 65355-33-1 / MFCD22379991 / 280.452 / C18H32O2

Ambeed / trans-4-Pentyl-(11-bicyclohexyl)-4-carboxylic acid / 1g / 552551796 / A123557 / / 65355-33-1 / MFCD22379991 / 280.452 / C18H32O2

ENCOMPASS_PREFERRED
3

eMolecules​ Ambeed / (E)-3-(3-chlorophenyl)-N-(2-((11-dioxidotetrahydro-2H-thiopyran-4-yl)(methyl)amino)-2-oxoethyl)acrylamide / 1mg / 491169168 / A183374 / / 1550008-55-3 / MFCD30187519 / 384.880 / C17H21ClN2O4S

Ambeed / (E)-3-(3-chlorophenyl)-N-(2-((11-dioxidotetrahydro-2H-thiopyran-4-yl)(methyl)amino)-2-oxoethyl)acrylamide / 1mg / 491169168 / A183374 / / 1550008-55-3 / MFCD30187519 / 384.880 / C17H21ClN2O4S

ENCOMPASS_PREFERRED
4

Medchemexpress LLC WDR5-IN-4 TFA | 2749300-35-2 | 98.0% | 612.40 | 1 ML
SDP

WDR5-IN-4 TFA (Compound C6) is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5), with a Kd of 0.1 nM. It displaces WDR5 from chromatin and decreases the expression of associated genes, leading to translational inhibition and nucleolar stress. This compound also exhibits anti-cancer activity.

  • Inhibits the proliferation of MLL1-rearranged cancer cells MV4:11 and K562 cells with GI50s of 3.20 μM and 25.4 μM respectively, when treated with 0-50 μM for 3 days.
  • Arrests the cell cycle of MV4:11 at the sub-G1 phase and induces apoptosis in MV4:11 when treated with 2 μM for 6 days.
  • Promotes Hox genes in hindbrains of Rnf220+/- mice at late embryonic stages with an intrauterine injection of 100 μg (single dose).

ENCOMPASS_PREFERRED